Introduction As the field of regenerative medicine continues to advance, the use of birth tissue and amniotic stem cell therapies holds promise for treating a variety of medical conditions. However, ensuring the safety and efficacy of these therapies requires robust regulatory oversight. In this article, we explore the challenges and considerations involved in regulating birth […]